GSK, Human Genome Escalate $2.6B Buyout Battle – site.law360.com

June 29, 2012 Posted By: Leave a comment
Law360, New York (June 29, 2012, 2:20 PM ET) -- GlaxoSmithKline PLC on Friday tried for the second time this month to entice Human Genome Sciences to agree to a $2.6 billion buyout, but the biopharmaceutical company rejected the unsolicited offer once ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>